HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new model of epidermal culture for the surgical treatment of vitiligo.

AbstractBACKGROUND:
Vitiligo can be successfully treated with grafts of autologous cultured epidermal cells.
OBJECTIVE:
To evaluate the efficacy of autologous grafting of epidermal cells, cultured by an original method, in the treatment of localized vitiligo refractory to other therapies.
METHODS:
Autologous normally pigmented skin was used to culture keratinocytes and melanocytes on a supporting layer of biomaterial (Laserskin), which was grafted directly onto achromatic skin after de-epithelialization with liquid carbon dioxide. The percentage area of repigmentation was calculated by image analysis.
RESULTS:
Initial repigmentation of the treated areas was observed 1 month after treatment. Repigmentation continued to increase for 3 months after grafting. Follow-up at 3, 6, 12, and 18 months showed almost complete repigmentation in six out of 11 cases. In four other patients, 40-71% of the grafted achromatic area was repigmented. In one patient, repigmentation was impeded by sepsis.
CONCLUSIONS:
The method was found to be effective in the treatment of localized vitiligo refractory to other treatments. The therapeutic procedure was simple, reproducible, and easy to use.
AuthorsL Andreassi, E Pianigiani, A Andreassi, P Taddeucci, M Biagioli
JournalInternational journal of dermatology (Int J Dermatol) Vol. 37 Issue 8 Pg. 595-8 (Aug 1998) ISSN: 0011-9059 [Print] England
PMID9732005 (Publication Type: Journal Article)
Chemical References
  • Biocompatible Materials
Topics
  • Adult
  • Aged
  • Biocompatible Materials
  • Cells, Cultured
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Skin (cytology)
  • Skin Transplantation
  • Transplantation, Autologous
  • Vitiligo (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: